Febuxostat (Brand Name Uloric): Drug Safety Communication - FDA to Evaluate Increased Risk of Heart-related Death
Date of publication: 15-11-2017
Preliminary safety trial results in over 6,000 patients with gout being evaluated. Źródło: https://www.fda.gov
